Monday, May 28, 2012
Advertisement

News: May 28, 2012

Cancer Drug May Boost Risk of Gastrointestinal Perforation
MONDAY, May 25 (HealthDay News) -- The use of the drug bevacizumab (Avastin) in combination with chemotherapy greatly increases the risk of gastrointestinal perforations in cancer patients, new research has found. These perforations are potentiall...
Healthline Tools
3D Body Maps
Advertisement
Healthline : Connect to Better Health

Follow on Twitter Follow on Facebook
More:
Site Map
MyHealthline
Health Directories:
Health and Wellness A to Z
Health Blogs A to Z
Diseases A to Z
Learning Centers A to Z
Drugs A to Z
Drugs by Disease
Supplements A to Z
Supplements by Disease
Symptoms A to Z
Symptoms by Disease
Slideshows A to Z
Videos A to Z
Videos by Disease
Company Info:
About Healthline.com
Editorial Staff
Terms of Use
Privacy Policy
Advertising & Sponsorship Policy
Advertise With Us
About Healthline Networks
Careers
Copyright © 2005 - 2012 Healthline Networks, Inc. All rights reserved.
Healthline is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendations. more details